Wintest
6721
Osaka Yuka Industry
4124
D. Western Therapeutics Institute
4576
Asiro
7378
Hamee
3134
(FY)Sep 30, 2023 | (FY)Sep 30, 2022 | (FY)Sep 30, 2021 | (FY)Sep 30, 2020 | (FY)Sep 30, 2019 | (FY)Sep 30, 2018 | (FY)Sep 30, 2017 | (FY)Sep 30, 2016 | |
---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||
Cash from operating activities | 19.81%997.5M | 29.15%832.58M | 67.00%644.68M | 331.36%386.03M | -53.53%89.49M | 206.15%192.59M | 62.43%62.91M | 38.73M |
Net profit before non-cash adjustment | 46.74%1.28B | 72.47%872.25M | 126.54%505.75M | 135.47%223.25M | -36.84%94.81M | 400.51%150.11M | 204.41%29.99M | ---28.73M |
Total adjustment of non-cash items | 116.52%123.15M | -0.09%56.87M | 9.72%56.93M | 158.48%51.89M | -59.65%20.07M | 330.24%49.74M | -63.82%11.56M | --31.96M |
-Depreciation and amortization | 64.02%110.89M | 30.18%67.61M | 23.11%51.93M | 112.84%42.18M | 49.04%19.82M | 52.97%13.3M | -6.08%8.69M | --9.26M |
-Disposal profit | ---- | ---- | ---- | ---- | --0 | ---- | ---- | --1.1M |
-Net exchange gains and losses | ---- | ---- | ---- | ---- | --115K | ---- | ---- | ---- |
-Other non-cash items | 214.20%12.26M | -314.89%-10.73M | -48.52%5M | 6,879.86%9.7M | -99.62%139K | 1,170.34%36.45M | -86.72%2.87M | --21.6M |
Changes in working capital | -320.10%-405.57M | -217.73%-96.54M | -26.05%82M | 536.62%110.89M | -249.47%-25.4M | -134.03%-7.27M | -39.85%21.35M | --35.5M |
-Change in receivables | -11.62%44.08M | 10.84%49.87M | 579.89%45M | 188.61%6.62M | -362.76%-7.47M | -113.50%-1.61M | 20.55%11.95M | --9.92M |
-Change in inventory | ---289M | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
-Change in prepaid assets | 21.75%-220.03M | -18,195.37%-281.2M | -93.60%1.55M | 159.55%24.27M | -255.73%-40.75M | -284.95%-11.46M | -120.49%-2.98M | --14.53M |
-Change in payables | 29.61%34.4M | 63.96%26.54M | -76.86%16.19M | 366.23%69.94M | 918.40%15M | -81.60%1.47M | -9.55%8.01M | --8.85M |
-Provision for loans, leases and other losses | 4.28%19.08M | -5.01%18.3M | 91.53%19.26M | 28.54%10.06M | 80.72%7.83M | -0.85%4.33M | 98.50%4.37M | --2.2M |
-Changes in other current assets | -93.45%5.89M | --89.95M | ---- | ---- | ---- | ---- | ---- | ---- |
Dividends paid (cash flow from operating activities) | ||||||||
Dividends received (cash flow from operating activities) | ||||||||
Interest paid (cash flow from operating activities) | -22.81%-716K | 10.17%-583K | 19.18%-649K | -55.32%-803K | 15.80%-517K | 38.54%-614K | 22.80%-999K | -1.29M |
Interest received (cash flow from operating activities) | -70.08%76K | 1,170.00%254K | -68.75%20K | 190.91%64K | 1,000.00%22K | 100.00%2K | 1K | |
Tax refund paid | -77.27%-375.76M | -69.16%-211.97M | -567.59%-125.31M | 73.99%-18.77M | -35,985.00%-72.17M | -10.50%-200K | -137.40%-181K | 484K |
Other operating cash inflow (outflow) | 0 | -1K | 0 | -100.00%-2K | -1K | 0 | 0 | 1K |
Operating cash flow | 0.13%621.1M | 19.57%620.28M | 41.53%518.74M | 2,078.28%366.52M | -91.23%16.83M | 210.68%191.78M | 62.78%61.73M | --37.92M |
Investing cash flow | ||||||||
Net PPE purchase and sale | -32.90%-42.88M | -9.22%-32.27M | -70.42%-29.54M | 64.65%-17.34M | -413.54%-49.03M | -86.59%-9.55M | -332.59%-5.12M | --2.2M |
Net intangibles purchase and sale | -49.97%-146.38M | -65.60%-97.61M | -53.69%-58.94M | -17.35%-38.35M | -609.18%-32.68M | -8.27%-4.61M | 26.23%-4.26M | ---5.77M |
Net business purchase and sale | ---- | ---- | ---- | ---- | ---165.91M | ---- | ---- | ---- |
Advance cash and loans provided to other parties | ---- | ---- | ---- | ---- | ---10M | ---- | ---- | ---- |
Net changes in other investments | 22.38%-10.8M | 46.21%-13.91M | -246.67%-25.87M | 92.16%-7.46M | -2,968.86%-95.2M | -6.82%-3.1M | -152.08%-2.9M | ---1.15M |
Investing cash flow | -39.14%-200.06M | -25.75%-143.79M | -81.08%-114.35M | 82.10%-63.15M | -1,944.39%-352.82M | -40.57%-17.26M | -160.05%-12.28M | ---4.72M |
Financing cash flow | ||||||||
Net issuance payments of debt | 51.58%-23.06M | -534.08%-47.63M | -116.69%-7.51M | -57.26%45M | 637.18%105.27M | -1,462.76%-19.6M | 92.94%-1.25M | ---17.77M |
Net common stock issuance | --0 | -83,370.25%-101M | 99.85%-121K | -4,493.42%-80.8M | -99.73%1.84M | 588.65%686.22M | 887.18%99.65M | --10.09M |
Cash dividends paid | -51.73%-88.22M | ---58.14M | ---- | ---- | ---- | ---- | ---- | ---- |
Net other fund-raising expenses | -37.31%11.48M | 232.61%18.31M | 644.51%5.51M | 89.03%-1.01M | -234.90%-9.21M | -383.48%-2.75M | 89.67%-569K | ---5.51M |
Financing cash flow | 47.04%-99.8M | -8,756.20%-188.46M | 94.22%-2.13M | -137.60%-36.81M | -85.25%97.9M | 578.64%663.87M | 842.21%97.82M | ---13.18M |
Net cash flow | ||||||||
Beginning cash position | 19.79%1.77B | 37.39%1.48B | 32.87%1.08B | -19.43%811.43M | 496.90%1.01B | 686.70%168.72M | 1,401.89%21.45M | --1.43M |
Current changes in cash | 11.53%321.24M | -28.40%288.03M | 50.91%402.27M | 211.96%266.56M | -128.40%-238.1M | 469.27%838.39M | 635.64%147.28M | --20.02M |
Effect of exchange rate changes | -95.09%254K | 533.33%5.17M | 377.19%816K | --171K | ---- | ---- | ---- | ---- |
Cash adjustments other than cash changes | ---- | ---- | --1K | ---- | 200.00%1K | -200.00%-1K | 200.00%1K | ---1K |
End cash Position | 18.12%2.1B | 19.79%1.77B | 37.39%1.48B | 40.20%1.08B | -23.64%769.02M | 496.90%1.01B | 686.70%168.72M | --21.45M |
Free cash flow | -11.94%431.84M | 13.98%490.41M | 38.42%430.26M | 579.04%310.83M | -136.53%-64.89M | 239.26%177.62M | 69.51%52.36M | --30.89M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |